Product NDC: | 51079-974 |
Proprietary Name: | Lovastatin |
Non Proprietary Name: | Lovastatin |
Active Ingredient(s): | 10 mg/1 & nbsp; Lovastatin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-974 |
Labeler Name: | Mylan Institutional Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075451 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121102 |
Package NDC: | 51079-974-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-974-20) > 1 TABLET in 1 BLISTER PACK (51079-974-01) |
NDC Code | 51079-974-20 |
Proprietary Name | Lovastatin |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-974-20) > 1 TABLET in 1 BLISTER PACK (51079-974-01) |
Product NDC | 51079-974 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lovastatin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121102 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional Inc. |
Substance Name | LOVASTATIN |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |